Rallying biotech looks ‘interesting’ for value investors, says top-rated analyst
July 21, 2016 at 14:08 PM EDT
Big drug discoveries have been scant, but investors can find long-term value in some biotech names, said Mark Schoenebaum of Evercore ISI.